Results summary | View all lists in GO:BiolProc | View all genes in G03D.profile.u50 |
The specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. enrichment: 2.46-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
210512_S_AT | VEGFA | G | D | X | S | vascular endothelial growth factor A | |||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
204203_AT | CEBPG | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), gamma | ||||||
221601_S_AT | FAIM3 | G | Fas apoptotic inhibitory molecule 3 | ||||||||||
201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
205481_AT | ADORA1 | G | T | D | X | C | S | adenosine A1 receptor | |||||
220038_AT | SGK3 | G | X | P | serum/glucocorticoid regulated kinase family, member 3 |